230 related articles for article (PubMed ID: 19762159)
21. Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.
Strzelczyk AA; Jarończyk M; Chilmonczyk Z; Mazurek AP; Chojnacka-Wójcik E; Sylte I
Biochem Pharmacol; 2004 Jun; 67(12):2219-30. PubMed ID: 15163553
[TBL] [Abstract][Full Text] [Related]
22. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
[TBL] [Abstract][Full Text] [Related]
23. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans.
Coccaro EF; Gabriel S; Siever LJ
Psychopharmacol Bull; 1990; 26(3):393-405. PubMed ID: 2274641
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C
J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
[TBL] [Abstract][Full Text] [Related]
25. Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects.
Isaac MB; Isaac MT
Hum Psychopharmacol; 2003 Oct; 18(7):569-74. PubMed ID: 14533141
[TBL] [Abstract][Full Text] [Related]
26. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
Lucki I
J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
[TBL] [Abstract][Full Text] [Related]
27. Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study.
Buritova J; Berrichon G; Cathala C; Colpaert F; Cussac D
Neuropharmacology; 2009 Feb; 56(2):350-61. PubMed ID: 18809418
[TBL] [Abstract][Full Text] [Related]
28. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
[TBL] [Abstract][Full Text] [Related]
29. Somatodendritic 5-hydroxytryptamine1A (5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone.
McAllister-Williams RH; Alhaj HA; Massey A; Pankiv J; Reckermann U
Psychol Med; 2014 Mar; 44(4):767-77. PubMed ID: 23809646
[TBL] [Abstract][Full Text] [Related]
30. 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone.
Cowen PJ; Power AC; Ware CJ; Anderson IM
Br J Psychiatry; 1994 Mar; 164(3):372-9. PubMed ID: 8199791
[TBL] [Abstract][Full Text] [Related]
31. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Maes M; Van Gastel A; Meltzer HY; Cosyns P; Blockx P; Desnyder R
Psychoneuroendocrinology; 1996 Jan; 21(1):67-81. PubMed ID: 8778905
[TBL] [Abstract][Full Text] [Related]
32. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
Cubała WJ; Landowski J
J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
[TBL] [Abstract][Full Text] [Related]
33. Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response.
Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Gastó C
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1804-9. PubMed ID: 18725263
[TBL] [Abstract][Full Text] [Related]
34. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation.
Blier P; Seletti B; Gilbert F; Young SN; Benkelfat C
Neuropsychopharmacology; 2002 Aug; 27(2):301-8. PubMed ID: 12093604
[TBL] [Abstract][Full Text] [Related]
35. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
36. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
[TBL] [Abstract][Full Text] [Related]
37. Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels.
Walker AJ; Burnett SA; Hasebe K; McGillivray JA; Gray LJ; McGee SL; Walder K; Berk M; Tye SJ
Behav Brain Res; 2013 Apr; 242():76-83. PubMed ID: 23276607
[TBL] [Abstract][Full Text] [Related]
38. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
[TBL] [Abstract][Full Text] [Related]
39. [Antidepressants, stressors and the serotonin 1A receptor].
Kirilly E; Gonda X; Bagdy G
Neuropsychopharmacol Hung; 2015 Jun; 17(2):81-9. PubMed ID: 26192901
[TBL] [Abstract][Full Text] [Related]
40. Buspirone and imipramine for the treatment of major depression in the elderly.
Schweizer E; Rickels K; Hassman H; Garcia-España F
J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
